Tue, April 9, 2019
Mon, April 8, 2019
Fri, April 5, 2019
Thu, April 4, 2019
Wed, April 3, 2019
Tue, April 2, 2019
Mon, April 1, 2019
Fri, March 29, 2019
Thu, March 28, 2019
Wed, March 27, 2019
Tue, March 26, 2019
Mon, March 25, 2019
Fri, March 22, 2019
Thu, March 21, 2019
Wed, March 20, 2019
Tue, March 19, 2019
Mon, March 18, 2019
Fri, March 15, 2019
Thu, March 14, 2019
Wed, March 13, 2019
Tue, March 12, 2019
Mon, March 11, 2019
Fri, March 8, 2019
Thu, March 7, 2019
Wed, March 6, 2019
Tue, March 5, 2019
Mon, March 4, 2019

Salim Syed Downgraded (BIIB) to Hold and Decreased Target to $235 on, Mar 22nd, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. nd-decreased-target-to-235-on-mar-22nd-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


Salim Syed of Mizuho, Downgraded "Biogen Inc." (BIIB) to Hold and Decreased Target from $416 to $235 on, Mar 22nd, 2019.

Salim has made no other calls on BIIB in the last 4 months.



There are 6 other peers that have a rating on BIIB. Out of the 6 peers that are also analyzing BIIB, all agree with Salim's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alethia Young of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Matt Phipps of "William Blair" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Steve Chesney of "Atlantic Equities" Downgraded from Buy to Hold on, Thursday, March 21st, 2019
  • Ian Somaiya of "BMO Capital" Initiated at Hold and Held Target at $322 on, Friday, February 22nd, 2019
  • Adnan Butt of "Guggenheim" Downgraded from Strong Buy to Hold and Decreased Target to $325 on, Friday, February 22nd, 2019
  • Thomas Shrader of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $346 on, Thursday, February 21st, 2019

Publication Contributing Sources